bpc 157 oral dosing protocol BPC-157 (Common Protocols), πΉ / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or bpc 157 dosage recommendations BPC-157
Description
There was wide variation in degree of improvement, with some participants experiencing little benefit, and some experiencing moderate or substantial benefit
Although some studies found an association of the Kiupel classification with a higher prognostic value [63,137], it is still recommended that both classification systems be used [15,138]
Quality sourcing remains critical since third-party tested peptides with 98% or higher purity deliver the most consistent results
Their ability to influence repair, inflammation, metabolism, and regeneration has made them valuable tools in both clinical and performance-based settings
Notice that even at the maximum dose of 15mg, you are drawing less than 0.9 mL
R.DongQ.RoughleyP.et al (2014)
